Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...

that evaluated a single dose of BRTX-100 vs a saline control in adults aged 18 to 60 years with pain associated with degenerative disc disease. Early results from the first 10 study participants ...

Discure Technologies, a clinical-stage medical device company pioneering treatments for degenerative disc disease and other orthopedic disorders, today announced its acceptance into the U.S. Food and ...

BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting –– IND ...

Spinal Stabilization Technologies enrolled its first U.S. patient in the Investigational Device Exemption clinical trial for its PerQdisc Nucleus Replacement Device.

A recent case that shocked my team and I involved a groundskeeper whose access to long-term disability (LTD) benefits for degenerative disc disease was cut off at the two-year mark. The individual ...

Degenerative disc disease (DDD) is associated with over 35 percent of all low back pain cases. Current treatments, including opioids, injections, and invasive surgery, focus on symptom relief and ...